Alex discusses the evolution of biotech, highlighting the lengthy process of drug development and the potential of gene therapies like Zolgensma for treating devastating diseases. The conversation delves into the future impact of nascent technologies in the biotech industry, paving the way for new breakthroughs in the next decade.
